Document:

IMPRIMIS
PHARMACEUTICALS, INC.

 

2017
INCENTIVE STOCK AND AWARDS PLAN

 

NOTICE
OF RESTRICTED STOCK AWARD

 

	 	Grantee’s
    Name and Address:	 
	 	 	 
	 	 	 

 

You
(the “Grantee”) have been granted shares of Common Stock of the Company (the “Award”), subject to the
terms and conditions of this Notice of Restricted Stock Award (the “Notice”), the Imprimis Pharmaceuticals, Inc. 2017
Incentive Stock and Awards Plan (the “Plan”), as amended from time to time, and the Restricted Stock Award Agreement
(the “Agreement”) attached hereto, as follows. Unless otherwise defined herein, the terms defined in the Plan shall
have the same defined meanings in this Notice.

 

	 	Award
    Number 	 
	 	 	 
	 	Date
    of Award 	 
	 	 	 
	 	Vesting
    Commencement Date 	 
	 	 	 
	 	Total
    Number of Shares	 
	 	of
    Common Stock Awarded (the “Shares”)	 

 

Vesting
Schedule:

 

Subject
to the Grantee continuing to be employed by or providing services to the Company or any Subsidiary and other limitations set forth
in this Notice, the Plan and the

 

For
purposes of this Notice and the Agreement, the term “vest” shall mean, with respect to any Shares, that such Shares
are no longer subject to forfeiture to the Company. Shares that have not vested are deemed “Restricted Shares.” If
the Grantee would become vested in a fraction of a Restricted Share, such Restricted Share shall not vest until the Grantee becomes
vested in the entire Share.

 

Except
as set forth above, vesting shall cease upon the date of termination of the Grantee’s employment or service for any reason
incluing death or Disability. In the event the Grantee’s employment or service is terminated for any reason, including death
or Disability, any Restricted Shares held by the Grantee immediately following such termination of employment or service shall
be deemed reconveyed to the Company and the Company shall thereafter be the legal and beneficial owner of the Restricted Shares
and shall have all rights and interest in or related thereto without further action by the Grantee. The foregoing forfeiture provisions
set forth in this Notice as to Restricted Shares shall apply to the new capital stock or other property (including cash paid other
than as a regular cash dividend) received in exchange for the Shares in consummation of any transaction described in Section 8
of the Plan and such stock or property shall be deemed Additional Securities (as defined in the Agreement) for purposes of the
Agreement, but only to the extent the Shares are at the time covered by such forfeiture provisions.

 

    	 	 1	 

     

    

 

IN
WITNESS WHEREOF, the Company and the Grantee have executed this Notice and agree that the Award is to be governed by the terms
and conditions of this Notice, the Plan and the Agreement.

 

	 	Imprimis
    Pharmaceuticals, Inc.,
	 	a
    Delaware corporation
	 	 	 
	 	By:   	 
	 	Title:
    	 

 

THE
GRANTEE ACKNOWLEDGES AND AGREES THAT THE SHARES SHALL VEST, IF AT ALL, ONLY DURING THE PERIOD OF THE GRANTEE’S EMPLOYMENT
OR SERVICE (NOT THROUGH THE ACT OF BEING HIRED, BEING GRANTED THIS AWARD OR ACQUIRING SHARES HEREUNDER). THE GRANTEE FURTHER ACKNOWLEDGES
AND AGREES THAT NOTHING IN THIS NOTICE, THE AGREEMENT NOR THE PLAN SHALL CONFER UPON THE GRANTEE ANY RIGHT WITH RESPECT TO CONTINUATION
OF THE GRANTEE’S EMPLOYMENT OR SERVICE, NOR SHALL IT INTERFERE IN ANY WAY WITH THE GRANTEE’S RIGHT OR THE COMPANY’S
RIGHT TO TERMINATE THE GRANTEE’S EMPLOYMENT OR SERVICE AT ANY TIME, WITH OR WITHOUT CAUSE, AND WITH OR WITHOUT NOTICE. THE
GRANTEE ACKNOWLEDGES THAT UNLESS THE GRANTEE HAS A WRITTEN EMPLOYMENT AGREEMENT WITH THE COMPANY TO THE CONTRARY, THE GRANTEE’S
STATUS IS AT WILL.

 

The
Grantee further acknowledges that, from time to time, the Company may be in a “blackout period” and/or subject to
applicable federal securities laws that could subject the Grantee to liability for engaging in any transaction involving the sale
of the Company’s Shares. The Grantee further acknowledges and agrees that, prior to the sale of any Shares acquired under
this Award, it is the Grantee’s responsibility to determine whether or not such sale of Shares will subject the Grantee
to liability under insider trading rules or other applicable federal securities laws.

 

The
Grantee understands that the Award is subject to the Grantee’s consent to access, and acknowledgement of having accessed,
the Plan prospectus in connection with the Form S-8 registration statement for the Plan, any updates thereto, the Plan, the Agreement
and this Notice (collectively, the “Plan Documents”) in electronic form through the [BROKER] web page at the following
address: [WEB ADDRESS] or such other address as is provided by notification from time to time. By accepting the grant of the Award,
the Grantee hereby: (i) consents to access electronic copies (instead of receiving paper copies) of the Plan Documents via the
[BROKER] web page or such other web page as is provided by notification from time to time, (ii) represents that the Grantee has
access to the internet generally; (iii) acknowledges receipt of electronic copies, or that the Grantee is already in possession
of paper copies, of the Plan Documents and the Company’s most recent annual report to shareholders; and (iv) represents
that the Grantee is familiar with the terms and provisions of the Plan Documents and accepts the Award subject to all of the terms
and provisions of the Plan Documents.

 

    	 	 2	 

     

    

 

The
Grantee may receive, without charge, upon written or oral request, paper copies of any or all of the Plan Documents, documents
incorporated by reference in the Form S-8 registration statement for the Plan, and the Company’s most recent annual report
to shareholders by requesting them from [Stock Administration] at Imprimis Pharmaceuticals, Inc., [ADDRESS], Attn. [Stock Administration].
Telephone [NUMBER], email: [INSERT EMAIL].

 

The
Grantee acknowledges receipt of a copy of the Plan and the Agreement and represents that he or she is familiar with the terms
and provisions thereof, and hereby accepts the Award subject to all of the terms and provisions hereof and thereof. The Grantee
has reviewed this Notice, the Agreement and the Plan in their entirety, has had an opportunity to obtain the advice of counsel
prior to executing this Notice and fully understands all provisions of this Notice, the Agreement and the Plan. The Grantee hereby
agrees that all questions of interpretation and administration relating to this Notice, the Plan and the Agreement shall be resolved
by the Administrator in accordance with Section 11 of the Agreement. The Grantee further agrees to the venue selection in accordance
with Section 12 of the Agreement. The Grantee further agrees to notify the Company upon any change in the residence address indicated
in this Notice.

 

	Dated:
    	 	 	Signed:
    	 

 

    	 	 3	 

     

    

 

Award
Number: __________________

 

IMPRIMIS
PHARMACEUTICALS, INC.

 

2017
INCENTIVE STOCK AND AWARDS PLAN

 

RESTRICTED
STOCK AWARD AGREEMENT

 

1.
Issuance of Shares. Imprimis Pharmaceuticals, Inc., a Delaware corporation (the “Company”), hereby issues to
the Grantee (the “Grantee”) named in the Notice of Restricted Stock Award (the “Notice”), the Total Number
of Shares of Common Stock Awarded set forth in the Notice (the “Shares”), subject to the Notice, this Restricted Stock
Award Agreement (the “Agreement”) and the terms and provisions of the Company’s 2017 Incentive Stock and Awards
Plan (the “Plan”), as amended from time to time, which are incorporated herein by reference. Unless otherwise defined
herein, the terms defined in the Plan shall have the same defined meanings in this Agreement. All Shares issued hereunder will
be deemed issued to the Grantee as fully paid and nonassessable shares, and the Grantee will have the right to vote the Shares
at meetings of the Company’s stockholders. The Company shall pay any applicable stock transfer taxes imposed upon the issuance
of the Shares to the Grantee hereunder.

 

2.
Transfer Restrictions. The Shares issued to the Grantee hereunder may not be sold, transferred by gift, pledged, hypothecated,
or otherwise transferred or disposed of by the Grantee prior to the date when the Shares become vested pursuant to the Vesting
Schedule set forth in the Notice. Any attempt to transfer Restricted Shares in violation of this Section 2 will be null and void
and will be disregarded.

 

3.
Escrow of Stock. For purposes of facilitating the enforcement of the provisions of this Agreement, the Grantee agrees,
immediately upon receipt of the certificate(s) for the Restricted Shares, to deliver such certificate(s), together with an Assignment
Separate from Certificate in the form attached hereto as Exhibit A, executed in blank by the Grantee with respect to each
such stock certificate, to the Secretary or Assistant Secretary of the Company, or their designee, to hold in escrow for so long
as such Restricted Shares have not vested pursuant to the Vesting Schedule set forth in the Notice, with the authority to take
all such actions and to effectuate all such transfers and/or releases as may be necessary or appropriate to accomplish the objectives
of this Agreement in accordance with the terms hereof. The Grantee hereby acknowledges that the appointment of the Secretary or
Assistant Secretary of the Company (or their designee) as the escrow holder hereunder with the stated authorities is a material
inducement to the Company to make this Agreement and that such appointment is coupled with an interest and is accordingly irrevocable.
The Grantee agrees that the Restricted Shares may be held electronically in a book entry system maintained by the Company’s
transfer agent or other third party and that all the terms and conditions of this Section 3 applicable to certificated Restricted
Shares will apply with the same force and effect to such electronic method for holding the Restricted Shares. The Grantee agrees
that such escrow holder shall not be liable to any party hereto (or to any other party) for any actions or omissions unless such
escrow holder is grossly negligent relative thereto. The escrow holder may rely upon any letter, notice or other document executed
by any signature purported to be genuine and may resign at any time. Upon the vesting of Restricted Shares, the escrow holder
will, without further order or instruction, transmit to the Grantee the certificate evidencing such Shares; provided, however,
that no transmittal of certificates evidencing the Shares will occur unless and until the Grantee has satisfied all Tax Withholding
Obligations (as defined in Section 5(c) below).

 

    	 	 1	 

     

    

 

4.
Additional Securities and Distributions.

 

(a)
Any securities or cash received (other than a regular cash dividend) as the result of ownership of the Restricted Shares (the
“Additional Securities”), including, but not by way of limitation, warrants, options and securities received as a
stock dividend or stock split, or as a result of a recapitalization or reorganization or other similar change in the Company’s
capital structure, shall be retained in escrow in the same manner and subject to the same conditions and restrictions as the Restricted
Shares with respect to which they were issued, including, without limitation, the Vesting Schedule set forth in the Notice. The
Grantee shall be entitled to direct the Company to exercise any warrant or option received as Additional Securities upon supplying
the funds necessary to do so, in which event the securities so purchased shall constitute Additional Securities, but the Grantee
may not direct the Company to sell any such warrant or option. If Additional Securities consist of a convertible security, the
Grantee may exercise any conversion right, and any securities so acquired shall constitute Additional Securities. In the event
of any change in certificates evidencing the Shares or the Additional Securities by reason of any recapitalization, reorganization
or other transaction that results in the creation of Additional Securities, the escrow holder is authorized to deliver to the
issuer the certificates evidencing the Shares or the Additional Securities in exchange for the certificates of the replacement
securities.

 

(b)
The Company shall disburse to the Grantee all regular cash dividends with respect to the Shares and Additional Securities (whether
vested or not), less any applicable withholding obligations.

 

5.
Taxes.

 

(a)
No Section 83(b) Election. As a condition to receiving the Shares, the Grantee agrees to refrain from making an election
pursuant to Section 83(b) of the Code with respect to the Shares.

 

(b)
Tax Liability. The Grantee is ultimately liable and responsible for all taxes owed by the Grantee in connection with the
Award, regardless of any action the Company or any Subsidiary takes with respect to any tax withholding obligations that arise
in connection with the Award. Neither the Company nor any Subsidiary makes any representation or undertaking regarding the treatment
of any tax withholding in connection with the grant or vesting of the Award or the subsequent sale of Shares subject to the Award.
The Company and its Subsidiaries do not commit and are under no obligation to structure the Award to reduce or eliminate the Grantee’s
tax liability.

 

(c)
Payment of Withholding Taxes. Prior to any event in connection with the Award (e.g., vesting) that the Company determines
may result in any tax withholding obligation, whether United States federal, state, local or non-U.S., including any employment
tax obligation (the “Tax Withholding Obligation”), the Grantee must arrange for the satisfaction of the minimum amount
of such Tax Withholding Obligation in a manner acceptable to the Company.

 

    	 	 2	 

     

    

 

(i)
By Share Withholding. The Grantee authorizes the Company to, upon the exercise of its sole discretion, withhold from those
Shares issuable to the Grantee the whole number of Shares sufficient to satisfy the minimum applicable Tax Withholding Obligation.
The Grantee acknowledges that the withheld Shares may not be sufficient to satisfy the Grantee’s minimum Tax Withholding
Obligation. Accordingly, the Grantee agrees to pay to the Company or any Subsidiary as soon as practicable, including through
additional payroll withholding, any amount of the Tax Withholding Obligation that is not satisfied by the withholding of Shares
described above.

 

(ii)
By Sale of Shares. Unless the Grantee determines to satisfy the Tax Withholding Obligation by some other means in accordance
with clause (iii) below, the Grantee’s acceptance of this Award constitutes the Grantee’s instruction and authorization
to the Company and any brokerage firm determined acceptable to the Company for such purpose to sell on the Grantee’s behalf
a whole number of Shares from those Shares issuable to the Grantee as the Company determines to be appropriate to generate cash
proceeds sufficient to satisfy the minimum applicable Tax Withholding Obligation. Such Shares will be sold on the day such Tax
Withholding Obligation arises (e.g., a vesting date) or as soon thereafter as practicable. The Grantee will be responsible for
all broker’s fees and other costs of sale, and the Grantee agrees to indemnify and hold the Company harmless from any losses,
costs, damages, or expenses relating to any such sale. To the extent the proceeds of such sale exceed the Grantee’s minimum
Tax Withholding Obligation, the Company agrees to pay such excess in cash to the Grantee. The Grantee acknowledges that the Company
or its designee is under no obligation to arrange for such sale at any particular price, and that the proceeds of any such sale
may not be sufficient to satisfy the Grantee’s minimum Tax Withholding Obligation. Accordingly, the Grantee agrees to pay
to the Company or any Subsidiary as soon as practicable, including through additional payroll withholding, any amount of the Tax
Withholding Obligation that is not satisfied by the sale of Shares described above.

 

(iii)
By Check, Wire Transfer or Other Means. At any time not less than five (5) business days (or such fewer number of business
days as determined by the Administrator) before any Tax Withholding Obligation arises (e.g., a vesting date), the Grantee may
elect to satisfy the Grantee’s Tax Withholding Obligation by delivering to the Company an amount that the Company determines
is sufficient to satisfy the Tax Withholding Obligation by (x) wire transfer to such account as the Company may direct, (y) delivery
of a certified check payable to the Company, or (z) such other means as specified from time to time by the Administrator.

 

Notwithstanding
the foregoing, the Company also may satisfy any Tax Withholding Obligation by offsetting any amounts (including, but not limited
to, salary, bonus and severance payments) due to the Grantee by the Company.

 

6.
Stop-Transfer Notices. In order to ensure compliance with the restrictions on transfer set forth in this Agreement, the
Notice or the Plan, the Company may issue appropriate “stop transfer” instructions to its transfer agent, if any,
and, if the Company transfers its own securities, it may make appropriate notations to the same effect in its own records. The
Company may issue a “stop transfer” instruction if the Grantee fails to satisfy any Tax Withholding Obligations.

 

    	 	 3	 

     

    

 

7.
Refusal to Transfer. The Company shall not be required (i) to transfer on its books any Shares that have been sold or otherwise
transferred in violation of any of the provisions of this Agreement or (ii) to treat as owner of such Shares or to accord the
right to vote or pay dividends to any purchaser or other transferee to whom such Shares shall have been so transferred.

 

8.
Restrictive Legends. The Grantee understands and agrees that the Company shall cause the legends set forth below or legends
substantially equivalent thereto, to be placed upon any certificate(s) evidencing ownership of the Shares together with any other
legends that may be required by the Company or by state or federal securities laws:

 

THE
SHARES REPRESENTED BY THIS CERTIFICATE ARE RESTRICTED BY THE TERMS OF THAT CERTAIN RESTRICTED STOCK AWARD AGREEMENT BETWEEN THE
COMPANY AND THE NAMED STOCKHOLDER. THE SHARES REPRESENTED BY THIS CERTIFICATE MAY BE TRANSFERRED ONLY IN ACCORDANCE WITH SUCH
AGREEMENT, A COPY OF WHICH IS ON FILE WITH THE SECRETARY OF THE COMPANY.

 

9.
Entire Agreement: Governing Law. The Notice, the Plan and this Agreement constitute the entire agreement of the parties
with respect to the subject matter hereof and supersede in their entirety all prior undertakings and agreements of the Company
and the Grantee with respect to the subject matter hereof, and may not be modified adversely to the Grantee’s interest except
by means of a writing signed by the Company and the Grantee. These agreements are to be construed in accordance with and governed
by the internal laws of the State of California without giving effect to any choice of law rule that would cause the application
of the laws of any jurisdiction other than the internal laws of the State of California to the rights and duties of the parties.
Should any provision of the Notice or this Agreement be determined to be illegal or unenforceable, the other provisions shall
nevertheless remain effective and shall remain enforceable.

 

10.
Construction. The captions used in the Notice and this Agreement are inserted for convenience and shall not be deemed a
part of the Award for construction or interpretation. Except when otherwise indicated by the context, the singular shall include
the plural and the plural shall include the singular. Use of the term “or” is not intended to be exclusive, unless
the context clearly requires otherwise.

 

11.
Administration and Interpretation. Any question or dispute regarding the administration or interpretation of the Notice,
the Plan or this Agreement shall be submitted by the Grantee or by the Company to the Administrator. The resolution of such question
or dispute by the Administrator shall be final and binding on all persons.

 

    	 	 4	 

     

    

 

12.
Venue and Waiver of Jury Trial. The parties agree that any suit, action, or proceeding arising out of or relating to the
Notice, the Plan or this Agreement shall be brought in the United States District Court for the Southern District of California
(or should such court lack jurisdiction to hear such action, suit or proceeding, in a California state court in the County of
San Diego) and that the parties shall submit to the jurisdiction of such court. The parties irrevocably waive, to the fullest
extent permitted by law, any objection the party may have to the laying of venue for any such suit, action or proceeding brought
in such court. If any one or more provisions of this Section 12 shall for any reason be held invalid or unenforceable, it is the
specific intent of the parties that such provisions shall be modified to the minimum extent necessary to make it or its application
valid and enforceable.

 

13.
Data Privacy. The Grantee hereby explicitly and unambiguously consents to the collection, use and transfer, in electronic
or other form, of the Grantee’s personal data as described in this Agreement by and among, as applicable, the Grantee’s
employer, the Company, and any Subsidiary for the exclusive purpose of implementing, administering and managing the Grantee’s
participation in the Plan. The Grantee understands that the Company or any Subsidiary may hold certain personal information about
the Grantee, including, but not limited to, the Grantee’s name, home address and telephone number, date of birth, social
security/insurance number or other identification number, salary, nationality, job title, any shares of Common Stock or directorships
held in the Company, details of all awards or any other entitlement to shares awarded, canceled, vested, unvested or outstanding
in the Grantee’s favor, for the purpose of implementing, administering and managing the Plan (“Data”). The Grantee
understands that Data may be transferred to any third parties assisting in the implementation, administration and management of
the Plan, that these recipients may be located in the Grantee’s country, or elsewhere, and that the recipient’s country
may have different data privacy laws and protections than the Grantee’s country. The Grantee understands that the Grantee
may request a list with the names and addresses of any potential recipients of the Data by contacting the Grantee’s local
human resources representative. The Grantee authorizes the recipients to receive, possess, use, retain and transfer the Data,
in electronic or other form, for the purposes of implementing, administering and managing the Grantee’s participation in
the Plan, including any requisite transfer of such Data as may be required to a broker, escrow agent or other third party with
whom the Shares received upon vesting of the Award may be deposited. The Grantee understands that Data will be held pursuant to
this Section 13 only as long as is necessary to implement, administer and manage the Grantee’s participation in the Plan.
The Grantee understands that the Grantee may, at any time, view Data, request additional information about the storage and processing
of Data, require any necessary amendments to Data or refuse or withdraw the consents herein, in any case without cost, by contacting
in writing the Grantee’s local human resources representative. The Grantee understands that refusal or withdrawal of consent
may affect the Grantee’s ability to participate in the Plan. For more information on the consequences of the Grantee’s
refusal to consent or withdrawal of consent, the Grantee understands that the Grantee may contact the Grantee’s local human
resources representative.

 

14.
Notices. Any notice required or permitted hereunder shall be given in writing and shall be deemed effectively given upon
personal delivery, upon deposit for delivery by an internationally recognized express mail courier service or upon deposit in
the United States mail by certified mail (if the parties are within the United States), with postage and fees prepaid, addressed
to the other party at its address as shown in these instruments, or to such other address as such party may designate in writing
from time to time to the other party.

 

    	 	 5	 

     

    

 

15.
Language. If the Grantee has received the Agreement or any other document related to the Plan translated into a language
other than English and if the meaning of the translated version is different than the English version, the English version will
control.

 

16.
Electronic Delivery. The Company may, in its sole discretion, decide to deliver any documents related to current or future
participation in the Plan by electronic means. The Grantee hereby consents to receive such documents by electronic delivery and
agrees to participate in the Plan through an on-line or electronic system established and maintained by the Company or a third
party designated by the Company.

 

17.
Imposition of Other Requirements. The Company reserves the right to impose other requirements on the Grantee’s participation
in the Plan, on the Award and on any Shares acquired under the Plan, to the extent the Company determines it is necessary or advisable
in order to comply with local law or facilitate the administration of the Plan, and to require the Grantee to sign any additional
agreements or undertakings that may be necessary to accomplish the foregoing.

 

END
OF AGREEMENT

 

    	 	6	 

    	 

    

 

EXHIBIT
A

 

STOCK
ASSIGNMENT SEPARATE FROM CERTIFICATE

 

FOR
VALUE RECEIVED, _______________________hereby sells, assigns and transfers unto _______________________, _________ (______) shares
of the Common Stock of Imprimis Pharmaceuticals, Inc., a Delaware corporation (the “Company”), standing in his name
on the books of, the Company represented by Certificate No. herewith, and does hereby irrevocably constitute and appoint the Secretary
of the Company attorney to transfer the said stock in the books of the Company with full power of substitution. 

 

	DATED:
    ________________	 
	 	 

 

[Please
sign this document but do not date it. The date and information of the transferee will be completed if and when the shares are
assigned.]IMPRIMIS
PHARMACEUTICALS, INC.

2017
INCENTIVE STOCK AND AWARDS PLAN

NOTICE
OF Restricted Stock Unit AWARD

 

	 	Grantee’s
    Name and Address:	 
	 	 	 
	 	 	 
	 	 	 
	 	 	 

 

You
(the “Grantee”) have been granted an award of Restricted Stock Units (the “Award”), subject to the terms
and conditions of this Notice of Restricted Stock Unit Award (the “Notice”), the Imprimis Pharmaceuticals, Inc. 2017
Incentive Stock and Awards Plan, as amended from time to time (the “Plan”) and the Restricted Stock Unit Agreement
(the “Agreement”) attached hereto, as follows. Unless otherwise provided herein, the terms in this Notice shall have
the same meaning as those defined in the Plan.

 

	 	Award
    Number 	 
	 	 	 
	 	Date
    of Award 	 
	 	 	 
	 	Vesting
    Commencement Date 	 
	 	 	 
	 	Total
    Number of Restricted Stock	 
	 	Units
    Awarded (the “Units”)	 

 

Vesting
Schedule:

 

Subject
to the Grantee continuing to be employed by or provide service to the Company or any Subsidiary and other limitations set forth
in this Notice, the Agreement and the Plan, the Units will “vest” in accordance with the following schedule (the “Vesting
Schedule”):

 

[Insert
Vesting Schedule].

 

In
the event of the Grantee’s change in status from an employee to a consultant or nonemployee director, the determination
of whether such change in status results in a termination of employment or service will be determined in accordance with Section
409A of the Code.

 

For
purposes of this Notice and the Agreement, the term “vest” shall mean, with respect to any Units, that such Units
are no longer subject to forfeiture to the Company. If the Grantee would become vested in a fraction of a Unit, such Unit shall
not vest until the Grantee becomes vested in the entire Unit.

 

Vesting
shall cease upon the date the Grantee terminates employment or service with the Company or any Subsidiary for any reason, including
death or Disability. In the event the Grantee terminates employment or service for any reason, including death or Disability,
any unvested Units held by the Grantee immediately upon such termination of the Grantee’s employment or service shall be
forfeited and deemed reconveyed to the Company and the Company shall thereafter be the legal and beneficial owner of such reconveyed
Units and shall have all rights and interest in or related thereto without further action by the Grantee.

 

    	 	 	 

    	 		 

    

 

IN
WITNESS WHEREOF, the Company and the Grantee have executed this Notice and agree that the Award is to be governed by the terms
and conditions of this Notice, the Plan, and the Agreement.

 

	 	IMPRIMIS
    PHARMACEUTICALS, INC.
	 	 	 
	 	a
    Delaware corporation
	 	 	 
	 	By:
    	 
	 	 	                           
	 	Title:
    	 
	 	 	 
	 	Date:
    	 

 

THE
GRANTEE ACKNOWLEDGES AND AGREES THAT THE UNITS SHALL VEST, IF AT ALL, ONLY DURING THE PERIOD OF THE GRANTEE’S EMPLOYMENT
OR SERVICE WITH THE COMPANY OR A SUBSIDIARY OR AS OTHERWISE SPECIFICALLY PROVIDED HEREIN (NOT THROUGH THE ACT OF BEING HIRED,
BEING GRANTED THIS AWARD OR ACQUIRING SHARES HEREUNDER). THE GRANTEE FURTHER ACKNOWLEDGES AND AGREES THAT NOTHING IN THIS NOTICE,
THE AGREEMENT, NOR IN THE PLAN, SHALL CONFER UPON THE GRANTEE ANY RIGHT WITH RESPECT TO CONTINUATION OF THE GRANTEE’S EMPLOYMENT
OR SERVICE, NOR SHALL IT INTERFERE IN ANY WAY WITH THE GRANTEE’S RIGHT OR THE COMPANY’S RIGHT TO TERMINATE THE GRANTEE’S
EMPLOYMENT OR SERVICE AT ANY TIME, WITH OR WITHOUT CAUSE, AND WITH OR WITHOUT NOTICE. THE GRANTEE ACKNOWLEDGES THAT UNLESS THE
GRANTEE HAS A WRITTEN EMPLOYMENT AGREEMENT WITH THE COMPANY TO THE CONTRARY, THE GRANTEE’S STATUS IS AT WILL.

 

    	 	 2	 

    	 		 

    

 

Grantee
Acknowledges and Agrees:

 

The
Grantee acknowledges receipt of a copy of the Plan and the Agreement and represents that he or she is familiar with the terms
and provisions thereof, and hereby accepts the Award subject to all of the terms and provisions hereof and thereof. The Grantee
has reviewed this Notice, the Agreement and the Plan in their entirety, has had an opportunity to obtain the advice of counsel
prior to executing this Notice and fully understands all provisions of this Notice, the Agreement and the Plan. The Grantee further
agrees and acknowledges that this Award is a non-elective arrangement pursuant to Section 409A of the Code.

 

The
Grantee further acknowledges that, from time to time, the Company may be in a “blackout period” and/or subject to
applicable federal securities laws that could subject the Grantee to liability for engaging in any transaction involving the sale
of the Company’s Shares. The Grantee further acknowledges and agrees that, prior to the sale of any Shares acquired under
this Award, it is the Grantee’s responsibility to determine whether or not such sale of Shares will subject the Grantee
to liability under insider trading rules or other applicable federal securities laws.

 

The
Grantee understands that the Award is subject to the Grantee’s consent to access this Notice, the Agreement, the Plan and
the Plan prospectus (collectively, the “Plan Documents”) in electronic form on the Company’s intranet or the
website of the Company’s designated brokerage firm, if applicable. By signing below (or providing an electronic signature
by clicking below) and accepting the grant of the Award, the Grantee: (i) consents to access electronic copies (instead of receiving
paper copies) of the Plan Documents via the Company’s intranet or the website of the Company’s designated brokerage
firm, if applicable; (ii) represents that the Grantee has access to the Company’s intranet [or the website of the Company’s
designated brokerage firm, if applicable]; (iii) acknowledges receipt of electronic copies, or that the Grantee is already in
possession of paper copies, of the Plan Documents; and (iv) acknowledges that the Grantee is familiar with and accepts the Award
subject to the terms and provisions of the Plan Documents.

 

The
Company may, in its sole discretion, decide to deliver any Plan Documents by electronic means or request the Grantee’s consent
to participate in the Plan by electronic means. The Grantee hereby consents to receive such documents by electronic delivery and
agrees to participate in the Plan through an on-line or electronic system established and maintained by the Company or a third
party designated by the Company.

 

The
Grantee hereby agrees that all questions of interpretation and administration relating to this Notice, the Plan and the Agreement
shall be resolved by the Administrator in accordance with Section 8 of the Agreement. The Grantee further agrees to the venue
and jurisdiction selection in accordance with Section 9 of the Agreement. The Grantee further agrees to notify the Company upon
any change in his or her residence address indicated in this Notice.

 

	Date:
    	 	 	 	 
	 	 	 	Grantee’s
    Signature
	 	 	 	 	 
	 	 	 	Grantee’s
    Printed Name
	 	 	 	 	 
	 	 	 	Address
	 	 	 	 	 
	 	 	 	City,
    State & Zip

 

    	 	 3	 

    	 		 

    

 

Award
Number: __________________

 

IMPRIMIS
PHARMACEUTICALS, INC.

2017
INCENTIVE STOCK AND AWARDS PLAN

 

RESTRICTED
STOCK UNIT AGREEMENT

 

1.
Issuance of Units. Imprimis Pharmaceuticals, Inc., a Delaware corporation (the “Company”), hereby issues to
the Grantee (the “Grantee”) named in the Notice of Restricted Stock Unit Award (the “Notice”) an award
(the “Award”) of the Total Number of Restricted Stock Units Awarded set forth in the Notice (the “Units”),
subject to the Notice, this Restricted Stock Unit Agreement (the “Agreement”) and the terms and provisions of the
Imprimis Pharmaceuticals, Inc. 2017 Incentive Stock and Awards Plan, as amended from time to time (the “Plan”), which
is incorporated herein by reference. Unless otherwise provided herein, the terms in this Agreement shall have the same meaning
as those defined in the Plan.

 

2.
Transfer Restrictions. The Units may not be transferred in any manner other than by will or by the laws of descent and
distribution.

 

3.
Conversion of Units and Issuance of Shares.

 

(a)
General. Subject to Sections 3(b) and 3(c), one share of Common Stock shall be issuable for each Unit subject to the Award
(the “Shares”) upon vesting. Immediately prior to the specified effective date of a Change in Control (each as defined
in the Plan) and subject to Sections 3(b) and 3(c), vesting shall accelerate and one Share shall be issuable for each Unit subject
to the Award. Immediately thereafter, or as soon as administratively feasible, the Company will transfer the appropriate number
of Shares to the Grantee after satisfaction of any required tax or other withholding obligations. Any fractional Unit remaining
after the Award is fully vested shall be discarded and shall not be converted into a fractional Share. Notwithstanding the foregoing,
the relevant number of Shares shall be issued no later than March 15th of the year following the calendar year in which the Award
vests.

 

(b)
Delay of Conversion. The conversion of the Units into the Shares under Section 3(a) above, shall be delayed in the event
the Company reasonably anticipates that the issuance of the Shares would constitute a violation of federal securities laws or
other applicable law. If the conversion of the Units into the Shares is delayed by the provisions of this Section 3(b), the conversion
of the Units into the Shares shall occur at the earliest date at which the Company reasonably anticipates issuing the Shares will
not cause a violation of federal securities laws or other applicable law. For purposes of this Section 3(b), the issuance of Shares
that would cause inclusion in gross income or the application of any penalty provision or other provision of the Code is not considered
a violation of applicable law.

 

(c)
Delay of Issuance of Shares. The Company shall delay the issuance of any Shares under this Section 3 to the extent necessary
to comply with Section 409A(a)(2)(B)(i) of the Code (relating to payments made to certain “specified employees” of
certain publicly-traded companies); in such event, any Shares to which the Grantee would otherwise be entitled during the six
(6) month period following the date of the Grantee’s termination of employment or service with the Company or a Subsidiary
will be issuable on the first business day following the expiration of such six (6) month period.

 

    	 	 	 

    	 

    

 

4.
Right to Shares. The Grantee shall not have any right in, to or with respect to any of the Shares (including any voting
rights or rights with respect to dividends paid on the Common Stock) issuable under the Award until the Award is settled by the
issuance of such Shares to the Grantee.

 

5.
Taxes.1

 

(a)
Tax Liability. The Grantee is ultimately liable and responsible for all taxes owed by the Grantee in connection with the
Award, regardless of any action the Company or any Subsidiary takes with respect to any tax withholding obligations that arise
in connection with the Award. Neither the Company nor any Subsidiary makes any representation or undertaking regarding the treatment
of any tax withholding in connection with any aspect of the Award, including the grant, vesting, assignment, release or cancellation
of the Units, the delivery of Shares, the subsequent sale of any Shares acquired upon vesting and the receipt of any dividends
or dividend equivalents. The Company does not commit and is under no obligation to structure the Award to reduce or eliminate
the Grantee’s tax liability.

 

(b)
Payment of Withholding Taxes. Prior to any event in connection with the Award (e.g., vesting) that the Company determines
may result in any tax withholding obligation, whether United States federal, state, local or non-U.S., including any social insurance,
employment tax, payment on account or other tax-related obligation (the “Tax Withholding Obligation”), the Grantee
must arrange for the satisfaction of the minimum amount of such Tax Withholding Obligation in a manner acceptable to the Company.

 

(i)
By Share Withholding. If permissible under applicable law, the Grantee authorizes the Company to, upon the exercise of
its sole discretion, withhold from those Shares otherwise issuable to the Grantee the whole number of Shares sufficient to satisfy
the minimum applicable Tax Withholding Obligation. The Grantee acknowledges that the withheld Shares may not be sufficient to
satisfy the Grantee’s minimum Tax Withholding Obligation. Accordingly, the Grantee agrees to pay to the Company or any Subsidiary
as soon as practicable, including through additional payroll withholding, any amount of the Tax Withholding Obligation that is
not satisfied by the withholding of Shares described above.

 

(ii)
By Sale of Shares. Unless the Grantee determines to satisfy the Tax Withholding Obligation by some other means in accordance
with clause (iii) below, the Grantee’s acceptance of this Award constitutes the Grantee’s instruction and authorization
to the Company and any brokerage firm determined acceptable to the Company for such purpose to, upon the exercise of Company’s
sole discretion, sell on the Grantee’s behalf a whole number of Shares from those Shares issuable to the Grantee as the
Company determines to be appropriate to generate cash proceeds sufficient to satisfy the minimum applicable Tax Withholding Obligation.
Such Shares will be sold on the day such Tax Withholding Obligation arises (e.g., a vesting date) or as soon thereafter as practicable.
The Grantee will be responsible for all broker’s fees and other costs of sale, and the Grantee agrees to indemnify and hold
the Company harmless from any losses, costs, damages, or expenses relating to any such sale. To the extent the proceeds of such
sale exceed the Grantee’s minimum Tax Withholding Obligation, the Company agrees to pay such excess in cash to the Grantee.
The Grantee acknowledges that the Company or its designee is under no obligation to arrange for such sale at any particular price,
and that the proceeds of any such sale may not be sufficient to satisfy the Grantee’s minimum Tax Withholding Obligation.
Accordingly, the Grantee agrees to pay to the Company or any Subsidiary as soon as practicable, including through additional payroll
withholding, any amount of the Tax Withholding Obligation that is not satisfied by the sale of Shares described above.

 

 

1
                                         Note to Draft: The tax withholding language has been drafted to provide the Company
                                         with flexibility in determining how the Company would like to handle tax withholding.
                                         However, we would note that for Section 16 purposes, if the Company were to determine
                                         at the time of settlement that it wished to cover tax withholding via net settlement,
                                         the net settlement will constitute a disposition for Section 16 purposes and will need
                                         to be reapproved at that time for any Section 16 officers to ensure that the disposition
                                         is exempt for Section 16b-3 purposes.

 

    	 	2	 

    	 

    

 

(iii)
By Check, Wire Transfer or Other Means. At any time not less than five (5) business days (or such fewer number of business
days as determined by the Administrator) before any Tax Withholding Obligation arises (e.g., a vesting date), the Grantee may
elect to satisfy the Grantee’s Tax Withholding Obligation by delivering to the Company an amount that the Company determines
is sufficient to satisfy the Tax Withholding Obligation by (x) wire transfer to such account as the Company may direct, (y) delivery
of a certified check payable to the Company, or (z) such other means as specified from time to time by the Administrator.

 

Notwithstanding
the foregoing, the Company or a Subsidiary also may satisfy any Tax Withholding Obligation by offsetting any amounts (including,
but not limited to, salary, bonus and severance payments) payable to the Grantee by the Company and/or a Subsidiary. Furthermore,
in the event of any determination that the Company has failed to withhold a sum sufficient to pay all withholding taxes due in
connection with the Award, the Grantee agrees to pay the Company the amount of such deficiency in cash within five (5) days after
receiving a written demand from the Company to do so, whether or not the Grantee is an employee of the Company at that time.

 

6.
Entire Agreement; Governing Law. The Notice, the Plan and this Agreement constitute the entire agreement of the parties
with respect to the subject matter hereof and supersede in their entirety all prior undertakings and agreements of the Company
and the Grantee with respect to the subject matter hereof, and may not be modified adversely to the Grantee’s interest except
by means of a writing signed by the Company and the Grantee. These agreements are to be construed in accordance with and governed
by the internal laws of the State of California without giving effect to any choice of law rule that would cause the application
of the laws of any jurisdiction other than the internal laws of the State of California to the rights and duties of the parties.
Should any provision of the Notice or this Agreement be determined to be illegal or unenforceable, the other provisions shall
nevertheless remain effective and shall remain enforceable.

 

7.
Construction. The captions used in the Notice and this Agreement are inserted for convenience and shall not be deemed a
part of the Award for construction or interpretation. Except when otherwise indicated by the context, the singular shall include
the plural and the plural shall include the singular. Use of the term “or” is not intended to be exclusive, unless
the context clearly requires otherwise.

 

    	 	3	 

    	 

    

 

8.
Administration and Interpretation. Any question or dispute regarding the administration or interpretation of the Notice,
the Plan or this Agreement shall be submitted by the Grantee or by the Company to the Administrator. The resolution of such question
or dispute by the Administrator shall be final and binding on all persons.

 

9.
Venue and Jurisdiction. The parties agree that any suit, action, or proceeding arising out of or relating to the Notice,
the Plan or this Agreement shall be brought exclusively in the United States District Court for the Southern District of California
(or should such court lack jurisdiction to hear such action, suit or proceeding, in a California state court in the County of
San Diego) and that the parties shall submit to the jurisdiction of such court. The parties irrevocably waive, to the fullest
extent permitted by law, any objection the party may have to the laying of venue for any such suit, action or proceeding brought
in such court. If any one or more provisions of this Section 9 shall for any reason be held invalid or unenforceable, it is the
specific intent of the parties that such provisions shall be modified to the minimum extent necessary to make it or its application
valid and enforceable.

 

10.
Notices. Any notice required or permitted hereunder shall be given in writing and shall be deemed effectively given upon
personal delivery, upon deposit for delivery by an internationally recognized express mail courier service or upon deposit in
the United States mail by certified mail (if the parties are within the United States), with postage and fees prepaid, addressed
to the other party at its address as shown in these instruments, or to such other address as such party may designate in writing
from time to time to the other party.

 

11.
Language. If the Grantee has received this Agreement or any other document related to the Plan translated into a language
other than English and if the translated version is different than the English version, the English version will control, unless
otherwise prescribed by applicable law.

 

12.
Amendment and Delay to Meet the Requirements of Section 409A. The Grantee acknowledges that the Company, in the exercise
of its sole discretion and without the consent of the Grantee, may amend or modify this Agreement in any manner and delay the
issuance of any Shares issuable pursuant to this Agreement to the minimum extent necessary to meet the requirements of Section
409A of the Code as amplified by any Treasury regulations or guidance from the Internal Revenue Service as the Company deems appropriate
or advisable. In addition, the Company makes no representation that the Award will comply with Section 409A of the Code and makes
no undertaking to prevent Section 409A of the Code from applying to the Award or to mitigate its effects on any deferrals or payments
made in respect of the Units. The Grantee is encouraged to consult a tax adviser regarding the potential impact of Section 409A
of the Code.

 

END
OF AGREEMENT

 

    	 	4

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00272-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00272-of-00352.parquet"}]]